Dupixent® (Dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age With Eosinophilic Esophagitis Published in the New England Journal of Medicine
Dupixent®(Dupilumab)在1至11歲患有嗜酸性食管炎兒童的三期積極數據已在《新英格蘭醫學雜誌》上發表。
Dupixent® (Dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age With Eosinophilic Esophagitis Published in the New England Journal of Medicine
Dupixent®(Dupilumab)在1至11歲患有嗜酸性食管炎兒童的三期積極數據已在《新英格蘭醫學雜誌》上發表。
譯文內容由第三人軟體翻譯。